Akura Medical is developing a thrombectomy device that utilizes a low-profile catheter to efficiently collect and fragment large clots in a single-pass procedure. This technology addresses the complexities and risks associated with current thrombectomy methods, providing a simpler and safer solution for treating venous thromboembolism.
Funding
$60M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CATCFounders
Product
Problem
Current methods for treating venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), present limitations such as high bleeding risk with thrombolytics, procedural complexity with mechanical thrombectomy devices, and difficulties in reaching the target clot. Existing treatments may also be inefficient in removing clots and can lead to significant blood loss.
Solution
Akura Medical is developing the Katana Thrombectomy System, a single-pass mechanical thrombectomy device designed for effective and easy removal of clots in patients with VTE. The system utilizes a low-profile catheter engineered to navigate complex anatomy and efficiently collect and fragment large, mixed morphology clots. The HydroBlade jets are designed to enable swift removal of a wide range of clot morphologies without causing catheter clogging. The Sentinel console provides clot engagement and clearance insights, as well as estimates of blood drawn, designed to reduce procedural uncertainty.
Target Audience
The primary target audience includes interventional cardiologists, vascular surgeons, and interventional radiologists treating patients with venous thromboembolism (VTE).
Features
- Low-profile catheter designed to navigate tortuous anatomy without crossing the clot
- HydroBlade jets intended for swift removal of a wide range of clot morphologies
- Sentinel console providing clot engagement and clearance insights, as well as estimates of blood drawn
- Single-pass procedure for efficient clot removal